THE-BRIJ
19.12.2022 12:53:36 CET | Business Wire | Press release
Serendipity Arts today announced its vision to bring the arts to life through a cutting-edge arts and culture centre, that will be a bridge that connects the world to the arts, and its transformational power. THE BRIJ will dedicate space, time, and resources to create ground-breaking art that is transformational and meaningful. Through this centre, Serendipity Arts also hopes to spark conversations around the arts across the South Asian region worldwide, assimilating regional flavours, traditions, and cultures, while also building a sustainable artistic ecosystem. The upcoming institution is named after and pays homage to late Mr. Brijmohan Lall Munjal, Indian industrialist and visionary, Mr. Sunil Kant Munjal’s father.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221218005083/en/
Outlining the idea behind THE BRIJ, Mr. Sunil Kant Munjal, Founder & Patron of Serendipity Arts and Founder of THE BRIJ, said, “Our privileges always come with responsibility; this initiative is a responsibility and a passion project for us. THE BRIJ stems from a responsibility we feel towards the arts; the way art is seen today, compared to how it was perceived in the region, prior to colonization. In terms of its programming, THE BRIJ will retain the aura of the flagship festival while adding multiple layers of practice, learning and experimentation to its programs, around the year. Planned around diverse creative practices, the facility will have higher arts education, incubation labs, centres of cultural innovation, performance spaces, and museums at a never-before-seen scale, in an interdisciplinary manner. In effect it will be the complete ecosystem for Arts & Culture at one place.”
The three essential elements of the Centre will be Education & Research, Multidisciplinary Experiences and Innovation & Incubation with training, workshops, and residencies. The one-of-its-kind centre is currently under construction and will have a Museum, an Academy & Workshop, a Gallery, Library, a Stepwell Gallery, an Arena, Theatre and Black Box, and much more. The facility will also house a crafts centre and an artisanal village, where dying and fringe art & craft forms will be brought back to life, through research, practice, and incubation. The entire campus has been designed in a way that it is 100 percent accessible to the differently abled.
With interdisciplinarity, education, and intergenerational exchange as its key purposes, THE BRIJ will emphasise excellence, change, innovation, equality, integrity, and responsibility. The aim is to gift the city of Delhi and the nation a cultural centre, enabling visitors with a shared passion and curiosity for the arts to cherish and immerse in it, inclusively. The centre hopes to create a space that attracts academics, intellectuals, students, art lovers, critics, artists, and members of the public, who can come together to create a bustling creative community.
With cutting-edge technologies that promise to bring forth unique and engaging experiences for visitors, THE BRIJ will be truly global in form and spirit. It will have all the ingredients for an inclusive and immersive experience with assisted navigation and omnichannel availability, while also driving the imperatives of sustainability through a reduced carbon footprint. At the same time, an efficient operational backend, a robust infrastructure for security and connectivity, and futuristic technologies will support the museum and the dream.
Speaking about THE BRIJ, Ms Smriti Rajgarhia, Director, Serendipity Arts Foundation and Festival, said, “THE BRIJ is our endeavour to strengthen India’s place in the global cultural dialogue and make international art accessible to the discerning and the common enthusiast. We aim to contribute to the cultural quotient of the region, through restored artworks and revival of lost or at-risk art forms, while also seeking to redefine the future of arts through interdisciplinary collaboration and innovation.”
Among the many features that make this cultural centre unique are the twin driving forces of economy and sustainability, both of which find expression through this building. THE BRIJ will also aim to meet the Foundation’s aspiration to emerge as a catalyst for change, by creating employment opportunities, contributing to India’s and New Delhi’s cultural economy and attracting both Indian and international tourists. Courtesy of Serendipity Arts, THE BRIJ already has and will further enhance its partnerships and exchanges with global institution and creative organizations, to build a facility with state-of-the-art infrastructure, that is organic and future facing.
The entire campus of THE BRIJ would have a platinum rating for green buildings and will generate more than 5200 direct and indirect employment. Besides, more than 120,000 people are expected to benefit from the education and skilling programmes that will be made available. About 90,000 young learners will have free access to the museum, with over 200 art start-ups and projects supported through the incubation centre. Through its multilateral and multicultural platform, the one-of-its-kind Museum hopes to significantly contribute to India’s GDP.
Speaking on the initiative, key member of our expert panel of architects, Mr. Dikshu Kukreja, Managing Principal, CP Kukreja Architects (CPKA), New Delhi, said, “The design philosophy for THE BRIJ is to create a co-existential architecture where the building and landscape dissolve into one. The architecture amplifies its context with buildings envisioned as magnified rock outcrops just like the quartzite rock formations found on the site. The design allows the adjoining forest to permeate into the site. All this as the vibrant and varied programmatic elements form a musical ensemble experiencing hitherto unexplored and futuristic sustainable design strategies.”
In addition to Mr Sunil Kant Munjal, THE BRIJ is also the dream of patron and social entrepreneur Shefali Munjal, Founder-Patron of THE BRIJ. The Board of Advisors include media personality and the current Chair of the Royal College of Arts, UK, Sir Peter Bazelgette; Harsh Goenka, Chairman of the RPG Group, an ardent collector of art and a strong advocate for fostering innovation; and Deepak Iyer, who heads the Accenture Microsoft Business group for Southeast Asia.
Advisors for THE BRIJ include poet, cultural theorist, and curator Ranjit Hoskote; Manu Chandra, Chef Partner for THE BRIJ and one of the pioneers of the gastropub scene in India; Shubha Mudgal, Padma Shri recipient and winner of the Gold Plaque Award for Special Achievement in Music at the Chicago International Film Festival; Aneesh Pradhan, noted table player; and Anuradha Kapur, recipient of the Sangeet Natak Award for Direction in Theatre and the instrumental figure at the National School of Drama, Delhi and Bangalore.
For more details, visit www.thebrij.world
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221218005083/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
